Differential induction of apoptosis in activated and resting T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its repercussion on T cell responsiveness1

Toxicology

Volumn 129, Issue 2-3, 1998, Pages 211-226

  Pryputniewicz, S J ^a   Nagarkatti, Mitzi ^b   Nagarkatti, Prakash S ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Apoptosis; Immunotoxicity; Proliferation; T cells; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE; IMMUNOTOXICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; APOPTOSIS; CELLS, CULTURED; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; TETRACHLORODIBENZODIOXIN;

ANIMALIA;

EID: 0032555772     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(98)00078-X     Document Type: Article

References (31)

1. al-Bayati Z.A.F., Murray W.J., Pankaskie M.C., Stohs S.J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced perturbation of calcium distribution in the rat. Res. Commun. Chem. Pathol. Pharmacol. 60:1988;47-56.
2. Badesha J.S., Maliji G., Flaks B. Immunotoxic effects of prolonged dietary exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Eur. J. Pharmacol. 293:1995;429-437.
3. Bombick D.W., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60c-src. J. Biochem. Tox. 2:1987;141-154.
4. Canga L., Levi R., Rifkind A.B. Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium. Proc. Natl. Acad. Sci. USA. 85:1988;905-909.
5. Choi E.J., Toscano D.G., Ryan J.A., Riedel N., Toscano Jr. W.A. Dioxin induces transforming growth factor-alpha in human keratinocytes. J. Biol. Chem. 266:1991;9591-9597.
6. Clark G.C., Blank J.A., Germolec D.R., Luster M.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression. Mol. Pharmacol. 39:1991a;495-501.
7. Clark G.C., Taylor M.J., Tritscher A.M., Lucier G.W. Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated endotoxin hypersensitivity in C57BL/6J mice congenic at the Ah locus. Tox. Appl. Pharmacol. 111:1991b;422.
8. Critchfield J.M., Racke M.K., Zuniga-Pflucker J.C., Cannella B., Raine C.S., Goverman J., Lenardo M.J. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science. 263:1994;1139-1143.
9. Dean T.N., Kakkanaiah V.N., Nagarkatti M., Nagarkatti P.S. Immunosuppression by aldicarb of T cell response to antigen-specific and polyclonal stimuli results from defective IL-1 production by the macrophage. Toxicol. Appl. Pharmacol. 106:1990;408-417.
10. Hernandez-Caselles T., Stutman O. Immune functions of tumor necrosis factor. I. tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J. Immunol. 151:1993;3999-4012.
11. Holsapple M.P., Snyder N.K., Wood S.C., Morris D.L. A Review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology. 69:1991;219-255.
12. Kamath A.B., Nagarkatti P.S., Nagarkatti M. Evidence for the induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in vivo. Toxicol. Appl. Pharmacol. 142:1997;367-377.
13. Kerkvliet N.I., Burleson G.R. Immunotoxicity of TCDD and related halogenated aromatic hydrocarbons. Dean J.H., Luster M.I. Immunotoxicology and Immunopharmacology. 2nd edn. 1994;97-121 Raven Press, New York.
14. Kerkvliet N.I., Baecher-Steppan L., Shepherd D.M., Oughton J.A., Vorderstrasse B.A., DeKrey G.K. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 157:1996;2310-2319.
15. Kramer C.M., Johnson K.W., Dooley R.K., Holsapple M.P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances antibody production and protein kinase activity in murine B cells. Biochem .Biophys. Res. Commun. 145:1987;25-33.
16. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature. 353:1991;858-861.
17. Lundberg K., Dencker L., Grovnik K.-O. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits the activation of antigen-specific T-cells in mice. Int. J. Immunopharm. 14:1992;699-705.
18. 2+-mediated endonuclease activation. Science. 242:1988;256-259.
19. McKallip R.J., Nagarkatti M., Nagarkatti P.S. Immunotoxicity of AZT: inhibitory effect on immunodeficiency virus. Toxicol. Appl. Pharmacol. 131:1995;53-62.
20. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
21. Neumann C.M., Oughton J.A., Kerkvliet N.I. Anti-CD3 induced T-cell activation II. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Int. J. Immunopharm. 15:1993;543-550.
22. Pereira G.M., Furtado G., de C., Yokoyama W.M., Kipnis T.L., Shevach E.M. Comparative aspects of T cell activation in vivo following stimulation with anti-CD3 mAb, allogeneic cells and Trypanosoma cruzi. Mem. Inst. Oswaldo. Cruz. 83:1988;284-290.
23. Poland A., Knutsen J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Ann. Rev. Pharmacol. Toxicol. 22:1982;517-554.
24. Rhile M.J., Nagarkatti M., Nagarkatti P.S. Role of Fas apoptosis and MHC genes in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity of T cells. Toxicology. 110:1996;153-167.
25. Rotello R.J., Lieberman R.C., Purchio A.F., Gerschenson L.E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;3412-3415.
26. Savill J., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today. 14:1993;131-136.
27. Sharma R.P., Gehring P.J. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on splenic lymphocyte transformation in mice after single and repeated exposures. Ann. N.Y. Acad. Sci. 320:1979;487-497.
28. Sutter T.R., Guzman K., Dold K.M., Greenlee W.F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science. 254:1991;415-418.
29. Tognoni G., Bonaccorsi A. Epidemiological problems with TCDD (a critical view). Drug. Metab. Rev. 13:1982;447-469.
30. Vos J.G., Van Loveren H., Schuurman H.-J. Immunotoxicity of dioxin: immune function and host resistance in laboratory animals and humans. Gallo M.A., Scheuplein R.J., Van Der Heijden K.A. Biological Basis for Risk Assessment of Dioxins and Related Compounds. Banbury Report 35. 1991;79-93 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
31. Worner W., Schrenk D. Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer. Res. 56:1996;1272-1278.